This article is devoted to the consideration of issues related to the legal mechanisms for stimulating the development of innovative technologies in the healthcare sector. In the course of the study, the features of the functioning of innovative infrastructure in the health sector in a number of foreign countries (USA, France, Canada, England) were highlighted. Four leading areas of stimulation of innovative development in medicine of foreign countries are identified: budget financing of science-intensive research; appropriate legal guarantees for the comfortable conduct of innovative research and the unhindered implementation of the results in the practice of medical organizations; modernization and re-equipment of research centers and laboratories; creation of territories with innovative infrastructure. It is concluded that the absence of clearly formulated by the domestic legislator directions for stimulating innovations and mechanisms for their implementation in practical medicine significantly slows down the processes of practical use of the country’s innovative potential. In this connection, the adaptation of the best foreign practices to stimulate the innovative development of medicine to the realities of Russian reality is an urgent necessity of the present.